1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Lymphatic Malformation: new trials by email Literature Review of Lymphatic Malformation trials Research Report on Lymphatic Malformation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations Sirolimus (RAPAMUNE) - Lymphatic Malformation | Phase 2 / Phase 3 | Recruiting | West China Hospital | 150 | 2024-11-30 | 2024-12-31 |
Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Hemic and Lymphatic Diseases (1) · Lymphatic Diseases (1)
Sirolimus (1)
China (1)
PMID 28782106, PMID 30240774, PMID 30980684, PMID 31236308, PMID 34524406, PMID 36044195, PMID 37717734, PMID 38390569